Growing health consciousness and evolving healthcare needs are creating rapidly growing markets for health products in both Indonesia and Australia. By leveraging each country’s strengths and addressing mutual health challenges, businesses can unlock large bilateral trade opportunities and foster a thriving cross border health products market.

The Market Opportunity Assessment identified opportunities in pharmaceuticals and complementary health products (CHPs) with therapeutic claims (which therefore require regulatory approval), including opportunities driven by demography, medical needs, bilateral trade and technological advances.

The Regulatory Landscape Assessment builds on the previous Market Opportunity Assessment that analysed opportunities for increasing bilateral trade and investment between Indonesia and Australia in pharmaceuticals and CHPs.